BigHat Biosciences

📍 San Mateo, United States🗓 Founded 2019👥 97 employees💰 Last funded Dec 2024
Biotechnology Research🌐 bighatbio.com
Website LinkedIn
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.
5
Total investors
2
Early stage
3
Mid stage
0
Late stage
2019
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
4
United Arab Emirates
1
Investor activity2019–2024 · investors recorded per year
2019120211202212023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in BigHat Biosciences?
BigHat Biosciences has 5 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage.
When did BigHat Biosciences last raise funding?
The most recent investment in BigHat Biosciences recorded on gritt.io was in December 2024.
When was BigHat Biosciences founded?
BigHat Biosciences was founded in 2019.
What industry is BigHat Biosciences in?
BigHat Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BigHat Biosciences based?
BigHat Biosciences is headquartered in San Mateo, United States.